title: New-onset psoriasis following treatment with the interleukin-1 receptor antagonist anakinra.
authors.forename: M A
authors.initials: MA
authors.lastname: González-López
authors.forename: V M
authors.initials: VM
authors.lastname: Martínez-Taboada
authors.forename: M C
authors.initials: MC
authors.lastname: González-Vela
authors.forename: H
authors.initials: H
authors.lastname: Fernández-Llaca
authors.forename: J F
authors.initials: JF
authors.lastname: Val-Bernal
mesh_terms: D000368:Aged; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D005260:Female; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein / Q000009:adverse effects*; D011565:Psoriasis / Q000139:chemically induced* / Q000473:pathology; D017472:Receptors, Interleukin-1 / Q000037:antagonists & inhibitors*
chemical_list: D018501:Antirheumatic Agents; D053590:Interleukin 1 Receptor Antagonist Protein; D017472:Receptors, Interleukin-1